TABLE 2

Summary of MIC results for 10 Mycoplasma hominis clinical isolates

Drug usedMIC data (μg/ml)No. (%) of resistant isolatesa
RangeMIC50MIC90
Chloramphenicol2–848NA
Ciprofloxacin≤0.25–10.51NA
Clindamycinb≤0.23≤0.23≤0.230
Doxycycline≤0.25≤0.25≤0.25NA
Gentamicinb2.6–10.45.25.2NA
Levofloxacin≤0.25–0.5≤0.25≤0.250
Linezolid1–848NA
Tetracycline≤0.25–10.510
  • a Resistance determined by using CLSI interpretive guidelines. NA, not applicable, as there are no established breakpoints. Breakpoints: levofloxacin, ≥2 μg/ml; clindamycin, ≥0.5 μg/ml; and tetracycline, ≥8 μg/ml.

  • b End MICs adjusted to account for drug potency.